Martí Farrera-Sal

Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager

Jana de Sostoa, Carlos Alberto Fajardo, Rafael Moreno et al. · Journal for ImmunoTherapy of Cancer · 2019 · 149 citations · Full text

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Guillem Pascual‐Pasto, Miriam Bazán‐Peregrino, Nagore G. Olaciregui et al. · Science Translational Medicine · 2019 · 109 citations

Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors

Rocio García‐Carbonero, Miriam Bazán‐Peregrino, Marta Gil-Martín et al. · Journal for ImmunoTherapy of Cancer · 2022 · 75 citations · Full text

Enhanced Antitumor Efficacy of Oncolytic Adenovirus–loaded Menstrual Blood–derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells

Rafael Moreno, Carlos Alberto Fajardo, Martí Farrera-Sal et al. · Molecular Cancer Therapeutics · 2018 · 42 citations

Oncolytic adenovirus with hyaluronidase activity that evades neutralizing antibodies: VCN-11

Ana Mato-Berciano, Sara Morgado, María Victoria Maliandi et al. · Journal of Controlled Release · 2021 · 25 citations

Immunology, Antiviral Response, Pathology +7